People: Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

8:48pm IST
Change (% chg)

$0.29 (+2.10%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Leung, Thomas 

Mr. Thomas Leung serves as Chief Financial Officer of the Company. Mr. Leung has served as our chief financial officer since April 2019. Prior to joining us, Mr. Leung served as vice president, business operations at Counsyl, Inc., a genetic screening company acquired by Myriad Genetics, Inc., where he held leadership roles in finance, strategy, billing operations and sales operations from August 2013 to April 2019. Prior to Counsyl, Mr. Leung served as a vice president of TPG Capital in San Francisco and Hong Kong, where he was responsible for sourcing investments, executing acquisitions and financings and managing portfolio companies. Mr. Leung began his career in investment banking at Morgan Stanley & Co. He holds an M.B.A. from Harvard Business School and received a B.S. in economics and biomedical engineering from Yale University.

Basic Compensation

Total Annual Compensation, USD 253,782
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,181,610
Fiscal Year Total, USD 2,435,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --